Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 2,464 shares
@ $67.8274, valued at
$167.1k
Sold 13,334 shares
@ $68.1523, valued at
$908.7k
Sold 15,508 shares
@ $68.5828, valued at
$1.1M
Sold 10,000 shares
@ $68.97, valued at
$689.7k
|
|
| 02/11/2022 |
4/A
| Doogan Declan (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 11,706 shares
@ $64.4221, valued at
$754.1k
Sold 13,333 shares
@ $64.7077, valued at
$862.7k
Sold 12,580 shares
@ $65.5513, valued at
$824.6k
Sold 13,334 shares
@ $66.0053, valued at
$880.1k
|
|
| 11/26/2021 |
4/A
| Conway Charles (Chief Scientific Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Granted 42,612 options to buy
@ $20.79, valued at
$885.9k
|
|
| 03/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/20/2018 |
4/A
| Berman Robert (Chief Medical Officer) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 4,409 shares
@ $35.25, valued at
$155.4k
Sold 55,907 shares
@ $36.15, valued at
$2M
Sold 100 shares
@ $36.65, valued at
$3.7k
Sold 10,647 shares
@ $37.07, valued at
$394.7k
Sold 5,629 shares
@ $38, valued at
$213.9k
|
|
| 05/11/2018 |
4/A
| Engelhart James (CFO) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Exercised 8,400 options to buy
@ $0.61, valued at
$5.1k
|
|
| 01/25/2018 |
4/A
| PORTAGE BIOTECH INC. (former 10% owner) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 35,119 shares
@ $30.03, valued at
$1.1M
Sold 24,277 shares
@ $33.15, valued at
$804.8k
|
|
| 01/11/2018 |
4/A
| PORTAGE BIOTECH INC. (10% Owner) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.|
Txns:
| Sold 4,350 shares
@ $28.6217, valued at
$124.5k
|
|
|
|